Anticoagulation Reversal and Treatment Strategies in Major Bleeding: Update 2016
Steve Christos, Robin Naples
doaj +1 more source
The Triad of Dying: A framework for palliation and compassionate decision-making in the ICU. [PDF]
Gilbert-Kawai N, Presswood E.
europepmc +1 more source
pH‐mediated activation of the lysosomal arginine sensor SLC38A9
Cells monitor nutrient levels via the lysosomal transporter SLC38A9 to activate the mechanistic target of rapamycin complex 1 (mTORC1). This study reveals that SLC38A9 function is regulated by pH. We identified histidine 544 as a critical pH sensor that undergoes conformational changes to control amino acid efflux from lysosomes; therefore, it ...
Xuelang Mu, Ampon Sae Her, Tamir Gonen
wiley +1 more source
Correction for Anand et al., Convolutional neural networks outperform other presence-only species distribution modeling algorithms. [PDF]
europepmc +1 more source
Microprolactinoma (Pituitary Adenoma) as a Cause of Secondary Headache in a Pediatric Patient With Pain and Restricted Mouth Opening: A Case Report. [PDF]
Draghici R +3 more
europepmc +1 more source
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice +16 more
wiley +1 more source
Newsroom: RWU Law Expands Providence Presence [PDF]
Roger Williams University School of Law
core +1 more source
Not simply two sides of the same coin: Target enhancement and distractor suppression draw on independent neural mechanisms. [PDF]
Khodayari N, Egeth H, Courtney SM.
europepmc +1 more source
Potential therapeutic targeting of BKCa channels in glioblastoma treatment
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak +4 more
wiley +1 more source

